Thymosin alpha 1 (Tα1) reduces the mortality of severe COVID-19 by restoration of lymphocytopenia and reversion of exhausted T cells

BACKGROUND: We previously reported that lymphocytopenia and T cell exhaustion is notable in acute COVID19 patients, especially in aged and severe cases. Thymosin alpha 1 (Tα1) had been used in the treatment of viral infections as an immune response modifier for many years. However, clinical benefits...

全面介紹

Na minha lista:
書目詳細資料
發表在:Clin Infect Dis
Main Authors: Liu, Yueping, Pang, Yue, Hu, Zhenhong, Wu, Ming, Wang, Chenhui, Feng, Zeqing, Mao, Congzheng, Tan, Yingjun, Liu, Ying, Chen, Li, Li, Min, Wang, Gang, Yuan, Zilin, Diao, Bo, Wu, Yuzhang, Chen, Yongwen
格式: Artigo
語言:Inglês
出版: Oxford University Press 2020
主題:
Major Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7314217/
https://ncbi.nlm.nih.gov/pubmed/32442287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciaa630
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍